Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
---|---|---|---|---|---|---|---|---|---|---|---|
VISTNVISTIN PHARMA ASA | 1.131 B NOK | 25.5 NOK | +0.39% | 12.9 K | 0.69 | 18.41 | 1.39 NOK | +37.91% | 1.96% | Health technology | — |
NYKDNYKODE THERAPEUTICS ASA | 783.712 M NOK | 2.400 NOK | −44.08% | 33.144 M | 39.60 | — | −1.27 NOK | +22.29% | 0.00% | Health technology | Strong buy |
LYTIXLYTIX BIOPHARMA AS | 331.397 M NOK | 6.68 NOK | −1.76% | 38.811 K | 1.06 | — | −1.85 NOK | — | 0.00% | Health technology | — |
BGBIOBERGENBIO ASA | 289.245 M NOK | 7.400 NOK | +5.71% | 130.542 K | 1.05 | — | −5.34 NOK | +87.14% | 0.00% | Health technology | Neutral |
ULTIULTIMOVACS ASA | 59.575 M NOK | 1.732 NOK | −6.38% | 51.715 K | 0.27 | — | −4.34 NOK | +26.84% | 0.00% | Health technology | Sell |
AABSARCTIC BIOSCIENCE AS | 49.978 M NOK | 1.97 NOK | −1.50% | 33.244 K | 0.09 | — | −1.91 NOK | −27.80% | 0.00% | Health technology | Neutral |